Yaxwer 120 mg solution for injection
*Company:
Gedeon Richter IrelandStatus:
NewLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
File name
HCP Cover Letter_Oct 2025_cl_HPRA approved 120 mg.pdf
Reasons for updating
- Add New Doc
File name
HCP Cover Letter_Oct 2025_cl_HPRA approved 120 mg.pdf
Reasons for updating
- Add New Doc
File name
Yaxwer RMM Patient Alert Card Ireland_05.pdf
Reasons for updating
- Add New Doc
Updated on 05 December 2025
File name
Yaxwer_SmPC_en_EU-1-25-1934-001--003.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 05 December 2025
File name
Yaxwer_PIL_en_EU-1-25-1934-001--003.pdf
Reasons for updating
- New PIL for new product
Gedeon Richter Ireland
 Ltd.webp)
Address:
4045 Kingswood Road, Citywest Business Campus, Dublin 24, IrelandMedical Information E-mail:
medinfo.uk@gedeonrichter.euTelephone:
00 44 207 604 8800Medical Information Direct Line:
00 44 207 604 8806